Dabsyl-L-tryptophan>98.0%(HPLC)100mg

(R)-TERT-BUTYL 2-((BENZYLOXY)METHYL)MORPHOLINE-4-CARBOXYLATE, 95.0%, 250mg

N-Ethyl-4-hydroxypiperidine, 95.0%, 1g

Mono V6TCI Size L

2-Chloro-4-(methylsulfonyl)benzoic Acid>98.0%(GC)(T)25g

1-Ethynyl-2,4-difluorobenzene>96.0%(GC)1g

Ethyl 3-methyl-4-pyridineacetate, 2.5g

(S)-2-Amino-4-((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(dimethylamino)propyl)amino)butanoic acid 2,2,2-trifluoroacetic acid salt, 97%, 10mg

tert-Butyl 4-nicotinoylpiperidine-1-carboxylate, 97%, 250mg

Ácido fórmico D solución al 95 % en D2O, 98 % atómico D, 5 ml, envase de vidrio

h-d-cys(trt)-oh, 97.0%, 5g

Tapa con brida plana DURAN® cuello central con NS, DN 120, 158 mm, Altura, 105 mm, 1 Pieza

(6-methyl-3-quinolinyl)boronic acid, 95.0%, 250mg